Jump to content
dlinds

Kaspersky Privilege Control question [MR1] [Pf116] [Solved]

Recommended Posts

Pf116 is for version 10.1.0.867 that resolves Application Startup Control corrupt message issue. Could you please tell what kind of issue do you experience exactly in details?

 

Thank You!

 

Hi Evgeny,

 

Can you please send the patch on INC000003640357.

 

Thanks !!

Share this post


Link to post
Hi Evgeny,

 

Can you please send the patch on INC000003640357.

 

Thanks !!

 

 

Hello.

Please wait for a reply within the incident.

 

Thanks.

Share this post


Link to post

I have the same problem, can you please send the private patch?

 

 

 

I have the same problem, can I get the Patch please

 

Thanks

 

Share this post


Link to post
I have the same problem, can you please send the private patch?

Hello.

 

To receive the patch, please create an incident in CompanyAccount, stating versions of your software along with the problem description.

Then please let us know the incident number.

Edited by MikroTik

Share this post


Link to post
Hello.

 

To receive the patch, please create an incident in CompanyAccount, stating versions of your software along with the problem description.

Then please let us know the incident number.

Hello,

please follow Mikrotik's advice.

Thanks.

Share this post


Link to post

Hello,

 

i have the same problem. i create ticket and the case number is: INC000003793810.

 

please send me the patch.

 

 

Thank you

 

Share this post


Link to post

Does the fix need to be installed on the Kaspersky server or on each individual PC? How can I get the fix?

Thanks!

Share this post


Link to post
Does the fix need to be installed on the Kaspersky server or on each individual PC? How can I get the fix?

Thanks!

 

Hi,

 

Pf116 is made for KES 10 (10.1.0.867). Patch installation options are described here. In order to receive the patch please submit a case and let us know its number.

 

Thank You!

Share this post


Link to post

×
×
  • Create New...

Important Information

We use cookies to make your experience of our websites better. By using and further navigating this website you accept this. Detailed information about the use of cookies on this website is available by clicking on more information.